[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Pages 38085-38086]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-15607]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Cayman Chemical Company

    By Notice dated March 8, 2012, and published in the Federal 
Register on March 20, 2012, 77 FR 16263, Cayman Chemical Company, 1180 
East Ellsworth Road, Ann Arbor, Michigan 48108, made application to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
4-Methyl-N-methylcathinone (1248)..........  I
Gamma Hydroxybutyric Acid (2010)...........  I
Mescaline (7381)...........................  I
N-Benzylpiperazine (7493)..................  I
3,4-Methylenedioxyprovalerone (7535).......  I
3,4-Methylenedioxy-N-methylcathinone (7540)  I
------------------------------------------------------------------------

    The company plans to manufacture the above listed controlled 
substances to supply these materials to the research and forensics 
community for drug testing and analysis.

[[Page 38086]]

    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cayman Chemical Company to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Cayman Chemical Company to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 
Sec.  1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: June 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-15607 Filed 6-25-12; 8:45 am]
BILLING CODE 4410-09-P